Shandong New Time Pharmaceutical
CompanyChina
Shandong New Time Pharmaceutical develops one asset, in phase 2 (F520 in cancer of unknown primary site). Mostly small molecule; based in China.
- 1
- Asset
- Furthest stage
- Phase 2
- 5
- Trials
- 1
- Signal
Pipeline
1Phase 2, Small molecule, cancer of unknown primary site
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Evidence behind the mechanisms1
- Trials5
- Signals1
- Similar companies5